Evolent Health, Inc.
$1.31B- Market cap
- $488.42M
- Debt
- +$970.54M
- Cash
- −$151.86M
Capital structure 33% equity / 67% debt · EV / Revenue 0.70x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: EVH stock price at discount vs WFRD $4.32 current versus $23.19 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WFRD's multiple
Implied fair value · at EVH's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EVH FY 2025 (ended Dec 31, 2025) · WFRD FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 33% equity / 67% debt · EV / Revenue 0.70x
Capital structure 83% equity / 17% debt · EV / Revenue 1.48x · EV / EBITDA 7.94x
WFRD carries the larger enterprise value at $7.30B against $1.31B; EVH trades on the lower EV / Revenue multiple (0.70x vs 1.48x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Evolent Health, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Weatherford International plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
2.34x
0.83x
Net debt / EBITDA
Leverage against operating earnings
-2.11x
0.47x
Cash and equivalents
Liquid reserves on the balance sheet
$151.86M
$987.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$970.54M
$1.42B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.